Merck KGaA ist einer der weltweit größten Pharma- und Chemiekonzerne. Der Umsatz ist auf folgende Produktfamilien verteilt:
Mitarbeiteranzahl : 58 096 Personen.
Umsatz nach Geschäftsbereich
2019 2020 Delta Life Science 6 864.00 42.5% 7 515.00 42.9% +9.48% Healthcare 6 714.00 41.6% 6 639.00 37.9% -1.12% Performance Materials 2 574.00 15.9% 3 380.00 19.3% +31.31%
EUR in Millionen
2019 2020 Delta United States 4 101.00 25.4% 4 639.00 26.5% +13.12% Asia Pacific 3 250.00 20.1% 3 738.00 21.3% +15.02% Europe 3 369.00 20.9% 3 552.00 20.3% +5.43% China 2 048.00 12.7% 2 224.00 12.7% +8.59% Germany 1 475.00 9.1% 1 501.00 8.6% +1.76% Latin America 965.00 6% 868.00 5% -10.05% Switzerland 389.00 2.4% 462.00 2.6% +18.77% Middle East and Africa 373.00 2.3% 361.00 2.1% -3.22% North America 182.00 1.1% 191.00 1.1% +4.95%
EUR in Millionen
Vote Menge Streubesitz Konzerneigene Aktien Total Float
Aktie A
1
129 242 252
129 242 252
100.0% 0
0.0% 29.7%
Aktie B
1
305 535 626
0
0.0% 0
0.0%
Aktionäre Merck KGaA (DE0006599905) MERCK Kommanditgesellschaft auf Aktien (US)
Name Aktien % Massachusetts Financial Services Co. 6 342 586
4,91% Select Equity Group LP 3 832 793
2,97% The Vanguard Group, Inc. 3 427 845
2,65% McKinley Capital Management LLC 3 348 185
2,59% Fidelity Management & Research Co. LLC 3 228 755
2,50% DWS Investment GmbH 2 800 374
2,17% Norges Bank Investment Management 2 542 168
1,97% Schroder Investment Management Ltd. 1 785 158
1,38% Thornburg Investment Management, Inc. 1 576 735
1,22% Deka Investment GmbH 1 434 640
1,11%
Name Aktien % Parametric Portfolio Associates LLC 782 161
0,12% Thomas White International Ltd. 624 487
0,097% Wells Capital Management, Inc. 106 000
0,016% Henry James International Management, Inc. 73 743
0,011% EQIS Capital Management, Inc. 50 265
0,0078% Aperio Group LLC 47 903
0,0074% Envestnet Asset Management, Inc. 34 616
0,0054% Lazard Asset Management LLC 24 237
0,0038% Murphy Capital Management, Inc. 20 667
0,0032% The Connable Office, Inc. 19 067
0,0030%
- Prime Standard
- DAX 30 / PEA, STOXX Europe 600
- Bloomberg Code :
MRK:GR
- Reuters Code :
MRCG.DE
- Datastream Code :
D:MRK
Merck KGaA
Frankfurter Strasse 250
DE-64293 Darmstadt, Hessen
Telefon : +49 (0)6151 72 0
Fax : +49 (0)6151 72 2000
Internet :
http://www.merck.de
Merck : plant Milliardeninvestitionen in Electronics-Geschäft
Branche Spezial- und fortgeschrittene Pharmazeutika
01.01. Wert (M$)
MERCK KGAA 44.92% 102 974
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD 62.61% 40 947
KYOWA KIRIN CO., LTD. 31.13% 17 360
SK BIOPHARMACEUTICALS CO., LTD. -42.01% 6 484
BETTA PHARMACEUTICALS CO., LTD. -21.95% 5 390
DOTTIKON ES HOLDING AG 95.59% 4 866
YUHAN CORPORATION -17.71% 3 431
RECIPHARM AB (PUBL) 6.02% 2 766
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. 4.16% 2 496
INDIVIOR PLC 110.85% 2 281
SUPERNUS PHARMACEUTICALS, INC. 16.77% 1 561
MEZZION PHARMA CO.,LTD. -7.74% 1 231
ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. -10.23% 1 228
KISSEI PHARMACEUTICAL CO., LTD. 6.88% 972
OSCOTEC INC. -52.52% 798
EAGLE PHARMACEUTICALS, INC. 12.33% 677
DBV TECHNOLOGIES 121.08% 613
HBM HOLDINGS LIMITED -38.92% 604
CALLIDITAS THERAPEUTICS AB (PUBL) -32.09% 577
NICHI-IKO PHARMACEUTICAL CO., LTD. -9.14% 546
KNIGHT THERAPEUTICS INC. -0.19% 529
Verbindungen : Merck KGaA
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
